Filed: 8/14/2023ACC: 0001420506-23-001564
📋 What this filing means
PROSIGHT MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 37 equity positions with a total reported market value of $325.80M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
37
Positions
$325.80M
Total AUM (reported)
35.84M
Total Shares
Allocation by class
COM$262.13M80.5%
SHS$30.10M9.2%
SPON ADR$16.98M5.2%
COM NEW$7.66M2.4%
COM CL A$5.89M1.8%
PUT$1.60M0.5%
CL A COM$765.6K0.2%
Portfolio Concentration
Top 3$81.23M24.9%
4–10$111.95M34.4%
11–25$110.57M33.9%
Rest$22.04M6.8%
Top 3 weight
24.9%
Top 10 weight
59.3%
Voting Authority Distribution
Total shares with voting rights: 35.74M
Sole
Full voting authority
35.74M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole37
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings37
Rows:
PACIRA BIOSCIENCES INC
SOLEShares877.59K
TypeSH
Market value$35.16M
10.79%
Sole
877.59K
Shared
0.00
None
0.00
HUMANA INC
SOLEShares55.10K
TypeSH
Market value$24.64M
7.56%
Sole
55.10K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares2.76M
TypeSH
Market value$21.43M
6.58%
Sole
2.76M
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares2.50M
TypeSH
Market value$17.60M
5.40%
Sole
2.50M
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares675K
TypeSH
Market value$17.46M
5.36%
Sole
675K
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares417.50K
TypeSH
Market value$16.98M
5.21%
Sole
417.50K
Shared
0.00
None
0.00
ABCELLERA BIOLOGICS INC
SOLEShares2.55M
TypeSH
Market value$16.47M
5.06%
Sole
2.55M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares170K
TypeSH
Market value$16.03M
4.92%
Sole
170K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares1.34M
TypeSH
Market value$14.21M
4.36%
Sole
1.34M
Shared
0.00
None
0.00
CENTENE CORP DEL
SOLEShares195.67K
TypeSH
Market value$13.20M
4.05%
Sole
195.67K
Shared
0.00
None
0.00
ADC THERAPEUTICS SA
SOLEShares5.58M
TypeSH
Market value$12.01M
3.68%
Sole
5.58M
Shared
0.00
None
0.00
KEZAR LIFE SCIENCES INC
SOLEShares4.65M
TypeSH
Market value$11.40M
3.50%
Sole
4.65M
Shared
0.00
None
0.00
MEIRAGTX HLDGS PLC
SOLEShares1.39M
TypeSH
Market value$9.35M
2.87%
Sole
1.39M
Shared
0.00
None
0.00
QUIDELORTHO CORP
SOLEShares110.47K
TypeSH
Market value$9.15M
2.81%
Sole
110.47K
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares120K
TypeSH
Market value$8.19M
2.51%
Sole
120K
Shared
0.00
None
0.00
NANOSTRING TECHNOLOGIES INC
SOLEShares2M
TypeSH
Market value$8.10M
2.49%
Sole
2M
Shared
0.00
None
0.00
OPTION CARE HEALTH INC
SOLEShares235.78K
TypeSH
Market value$7.66M
2.35%
Sole
235.78K
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
SOLEShares15K
TypeSH
Market value$7.21M
2.21%
Sole
15K
Shared
0.00
None
0.00
INARI MED INC
SOLEShares118.68K
TypeSH
Market value$6.90M
2.12%
Sole
118.68K
Shared
0.00
None
0.00
SHATTUCK LABS INC
SOLEShares2.11M
TypeSH
Market value$6.58M
2.02%
Sole
2.11M
Shared
0.00
None
0.00
LONGBOARD PHARMACEUTICALS IN
SOLEShares734.90K
TypeSH
Market value$5.39M
1.66%
Sole
734.90K
Shared
0.00
None
0.00
MEDTRONIC PLC
SOLEShares60K
TypeSH
Market value$5.29M
1.62%
Sole
60K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares147.55K
TypeSH
Market value$4.62M
1.42%
Sole
147.55K
Shared
0.00
None
0.00
GRAPHITE BIO INC
SOLEShares1.70M
TypeSH
Market value$4.42M
1.36%
Sole
1.70M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares1.56M
TypeSH
Market value$4.30M
1.32%
Sole
1.56M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PACIRA BIOSCIENCES INCSOLE | COM | 877.59K | SH | $35.16M 10.79% | 877.59K | 0.00 | 0.00 |
HUMANA INCSOLE | COM | 55.10K | SH | $24.64M 7.56% | 55.10K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 2.76M | SH | $21.43M 6.58% | 2.76M | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 2.50M | SH | $17.60M 5.40% | 2.50M | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 675K | SH | $17.46M 5.36% | 675K | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 417.50K | SH | $16.98M 5.21% | 417.50K | 0.00 | 0.00 |
ABCELLERA BIOLOGICS INCSOLE | COM | 2.55M | SH | $16.47M 5.06% | 2.55M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 170K | SH | $16.03M 4.92% | 170K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 1.34M | SH | $14.21M 4.36% | 1.34M | 0.00 | 0.00 |
CENTENE CORP DELSOLE | COM | 195.67K | SH | $13.20M 4.05% | 195.67K | 0.00 | 0.00 |
ADC THERAPEUTICS SASOLE | SHS | 5.58M | SH | $12.01M 3.68% | 5.58M | 0.00 | 0.00 |
KEZAR LIFE SCIENCES INCSOLE | COM | 4.65M | SH | $11.40M 3.50% | 4.65M | 0.00 | 0.00 |
MEIRAGTX HLDGS PLCSOLE | COM | 1.39M | SH | $9.35M 2.87% | 1.39M | 0.00 | 0.00 |
QUIDELORTHO CORPSOLE | COM | 110.47K | SH | $9.15M 2.81% | 110.47K | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 120K | SH | $8.19M 2.51% | 120K | 0.00 | 0.00 |
NANOSTRING TECHNOLOGIES INCSOLE | COM | 2M | SH | $8.10M 2.49% | 2M | 0.00 | 0.00 |
OPTION CARE HEALTH INCSOLE | COM NEW | 235.78K | SH | $7.66M 2.35% | 235.78K | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCSOLE | COM | 15K | SH | $7.21M 2.21% | 15K | 0.00 | 0.00 |
INARI MED INCSOLE | COM | 118.68K | SH | $6.90M 2.12% | 118.68K | 0.00 | 0.00 |
SHATTUCK LABS INCSOLE | COM | 2.11M | SH | $6.58M 2.02% | 2.11M | 0.00 | 0.00 |
LONGBOARD PHARMACEUTICALS INSOLE | COM | 734.90K | SH | $5.39M 1.66% | 734.90K | 0.00 | 0.00 |
MEDTRONIC PLCSOLE | SHS | 60K | SH | $5.29M 1.62% | 60K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 147.55K | SH | $4.62M 1.42% | 147.55K | 0.00 | 0.00 |
GRAPHITE BIO INCSOLE | COM | 1.70M | SH | $4.42M 1.36% | 1.70M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 1.56M | SH | $4.30M 1.32% | 1.56M | 0.00 | 0.00 |
Page 1 of 2